Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype-Reference-Cited by-同舟云学术

Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype

Published:2019-06-27 Issue:7 Volume:40 Page:1149-1155
ISSN:0195-6108
Container-title:American Journal of Neuroradiology
language:en
Short-container-title:AJNR Am J Neuroradiol

Author:

Patel S.H.^ORCID,Bansal A.G.^ORCID,Young E.B.^ORCID,Batchala P.P.^ORCID,Patrie J.T.^ORCID,Lopes M.B.^ORCID,Jain R.^ORCID,Fadul C.E.^ORCID,Schiff D.^ORCID

Funder

RSNA Research and Education Foundation

Publisher

American Society of Neuroradiology (ASNR)

Subject

Clinical Neurology,Radiology Nuclear Medicine and imaging

Reference30 articles.

1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2. IDH1andIDH2Mutations in Gliomas

3. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

4. Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in Tumors

5. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling hierarchy and spatial distribution of O⁶‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas;Cancer Science;2024-08-05

2. Effects of the Use of Neuronavigation in Patients with Supratentorial Brain Gliomas: A Cohort Study;World Neurosurgery;2024-07

3. Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes;World Neurosurgery: X;2024-07

4. Clear neuroimaging margin at the brain-tumor interface is associated with gross total resection and longer survival in non-enhancing diffuse gliomas;Journal of Neurosurgical Sciences;2024-05

5. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy;Brain Tumor Pathology;2024-04